Financials Please be advised that the information posted was accurate at the time of posting, but may be superseded by subsequent news releases. These documents are in Adobe Acrobat (pdf) format. For viewing, download and install the Acrobat Reader 6.0. Interim reports Second quarter ended June 30, 2010 (618K) First quarter ended March 31, 2010 (274K) Third quarter ended September 30, 2009 (707K) Second quarter ended June 30, 2009 (334K) First quarter ended March 31, 2009 (238K) Third quarter ended September 30, 2008 (605K) Second quarter ended June 30, 2008 (187K) First quarter ended March 31, 2008 (187K) Third quarter ended September 30, 2007 (523K) Second quarter ended June 30, 2007 (324K) First quarter ended March 31, 2007 (370K) Third quarter ended September 30, 2006 (restated) (323K) Second quarter ended June 30, 2006 (319K) First quarter ended March 31, 2006 (322K) Third quarter ended September 30, 2005 (163K) Second quarter ended June 30, 2005 (202K) First quarter ended March 31, 2005 (410K) Third quarter ended September 30, 2004 (194K) Second quarter ended June 30, 2004 (127K) First quarter ended March 31, 2004 (55K) Other Unaudited last eight quarters in USD ending June 30, 2007 (56K) Annual reports 2009 Annual Report Financials: 2009 Audited Annual Financial Statements (PDF: 768 Kb) Management’s Discussion and Analysis of Financial Condition and Results of Operation (PDF: 460 Kb) Message to Shareholders (PDF: 67 Kb) 2008 Annual Report Financials: 2008 Audited Annual Financial Statements (PDF: 692 Kb) Management’s Discussion and Analysis of Financial Condition and Results of Operation (PDF: 353 Kb) Message to Shareholders (PDF: 60 Kb) 2007 Annual Report (Complete PDF: 740 Kb) 2007 Annual Report (Detailed documents) Intro and Highlights (PDF: 256 Kb) Message to Shareholders (PDF: 119 Kb) Aeterna Zentaris Pipeline (PDF: 324 Kb) Lead Endocrinology Program (PDF: 90 Kb) Lead Oncology Program (PDF: 80 Kb) Partnered Clinical Programs (PDF: 80 Kb) 2008 Upcoming Milestones (PDF: 126 Kb) Experienced Management Team (PDF: 70 Kb) Company Overview (PDF: 42 Kb) Financials: 2007 Audited Annual Financial Statements (PDF: 299 Kb) Management’s Discussion and Analysis of Financial Condition and Results of Operation (PDF: 122 Kb) 2006 Annual Report (Complete PDF: 1 Mb) 2006 Annual Report (Detailed documents) Profile, Strengths and Highlights 2006 (PDF: 212 Kb) Message to Shareholders (PDF: 140 Kb) New Focused Drug Development Stategy (PDF: 32 Kb) Drug Pipeline (PDF: 56 Kb) Three Main Products (PDF: 56 Kb) Large Market Opportunities (PDF: 24 Kb) Goals for 2007 (PDF: 80 Kb) Investment Opportunity (PDF: 172 Kb) Directors & Senior Officers (PDF: 84 Kb) Scientific Advisory Board & Corporate Information (PDF: 84 Kb) Financials: 2006 Annual Financial Statements dated September 17, 2007.pdf (PDF: 266 Kb) Management’s Discussion and Analysis of Financial Condition and Results of Operation (PDF: 104 Kb) Management’s Reports (PDF: 40 Kb) Annual information form Form 20-F – 2009 (3300K) Form 20-F – 2008 (1300K) Form 20-F – 2007 Annual information form 2006 (365K) Filings Canada filings USA filings

Term and conditions of use. Safe harbor and privacy policy. Copyright © 2004 Æterna Zentaris Inc. All rights reserved. Use of this site signifies your agreement to the terms of use.